The first and only topical gel for the treatment of Facial Angiofibroma in tuberous sclerosis complex (TSC) approved by the Food and Drug Administration for adults and children 6 years and older

HYFTOR® is a clear gel that contains
the mTOR inhibitor sirolimus.

Not an actual patient. Individual results may vary.
The First and Only
FDA-approved HYFTOR® is for patients 6 years of age and older who have Facial Angiofibroma—one of the most visible signs of TSC. Ask your doctor if HYFTOR® is right for you and help you treat your Facial Angiofibroma.
The first and only topical gel for the treatment of Facial Angiofibroma in tuberous sclerosis complex (TSC) approved by the Food and Drug Administration for adults and children 6 years and older

HYFTOR® is a clear gel that contains the mTOR inhibitor sirolimus.

What are TSC and Facial Angiofibroma?
Learn more about TSC, Facial Angiofibroma, and the effects they can have on people’s lives.
You may be eligible to pay as little as $0*
You may be eligible to pay as little as $0 per month through the HYFTOR® Co-Pay Program.
Important Safety Information
What is HYFTOR®? HYFTOR® is a prescription medicine that is used on the skin (topical) to treat adults and children 6 years of age and older with a type of noncancerous tumor called angiofibroma on your face caused by the genetic condition tuberous sclerosis. It is not known if HYFTOR® is safe and effective in children under 6 years of age.
Important: HYFTOR® is for use on the skin only (topical use). Do not use HYFTOR® in your mouth, eyes, or vagina.